Xoma Corp Reports Results For The Quarter Ended In December: Earnings Summary

Xoma Royalty

08/03/2024 15:11

* XOMA Corp  XOMA.OQ  reported a quarterly adjusted loss
of 49
cents​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -63
cents.  The mean expectation of two analysts for the quarter was
for a loss of 36 cents per share. Wall Street expected
results to range from -59 cents to -13 cents per share.
    * Revenue rose 23.4% to $1.83 million from a year ago;
analysts
expected $3.61 million. 
    * XOMA Corp's reported EPS for the quarter was a loss of
$1.87​.
    * The company reported a quarterly loss of $21.48 million.
    * XOMA Corp shares had risen by 35.8% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "hold."

Wall Street's median 12-month price target for XOMA Corp is
$74.00 
This summary was machine generated from LSEG data March 8 at
03:11 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.36          -0.49          Missed
 Sep. 30 2023      -0.48          -0.60          Missed
 Jun. 30 2023      -0.52          -0.45          Beat
 Mar. 31 2023      -0.50          -0.62          Missed